Bolden

The two women behind this label first crossed paths as high-school classmates in Nigeria, long before either imagined a beauty company. One left home at sixteen to study in New York, earned an economics degree, worked in finance and technology, then served as an economist for a government bureau before completing an MBA at MIT; the other took a parallel route through business school. Their professional instincts, spreadsheets, supply chains, market gaps, shaped a venture that reads less like a passion project and more like a thesis. The catalyst was mundane and specific: a Key West vacation where the only sunscreen on hand dried to a chalky gray film on their skin, a daily indignity familiar to anyone with deeper complexions and one the mass market had quietly ignored. They incorporated the business in early 2012 and spent the following years on formulation and testing before products reached shelves in 2015. The early range stayed deliberately narrow, a clarifying cleanser, a glycolic toner, a daily SPF moisturizer, treating brightening, gentle exfoliation, and sun protection as the unglamorous fundamentals most routines actually need. Operating without outside investors forced discipline; when a pandemic-era stockout left the toner unavailable for months, they relocated operations closer to their manufacturer to tighten production cycles, a logistics lesson rather than a branding one. A 2019 placement tied to a retailer diversity push eventually dissolved, but the brand pivoted into a nationwide warehouse-club and big-box footprint, a harder, more durable channel for an independently held company. Later launches like a targeted dark-spot treatment extended the same pragmatic logic. What distinguishes the line is not a proprietary molecule but a point of view: high-quality basics, priced for everyday use, built first for the skin tones the category overlooked.

Sources:[1][2][3]